Rajesh Thangapazham PhD, RAC

Rajesh Thangapazham a Regulatory Affairs professional, specializing in regenerative medicine, cell and gene therapies, advanced therapy medicinal products, and other enabling emerging technologies such as automated and closed-cell processing systems and single-use disposables. He has extensive experience and background in preclinical drug development and has developed working models that are pivotal to study the pharmacology and toxicology of small molecules and nutraceuticals for cancer therapies, scarless skin regeneration, and hair follicle neogenesis, and to ensure the safety and efficacy of cellular and gene therapies. In addition to the strong expertise in the regulatory process, He has developed lateral skills in developing intellectual property material and commercialization strategies for biopharmaceuticals.